Company / CapEx per Share
Beam Therapeutics Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.15
FY2025
5-year range
$0.11 / $0.69
FY2021-FY2025
Trend
+37.3%
vs FY2024
Sector context
#48 of 192
Health Care
What the data says
Beam Therapeutics Inc.'s capex per share of $0.15 is higher than 75% of companies in the Health Care sector (FY2025). CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.15.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of -38.8%. Top quartile in the Health Care sector.
Declined from $0.41 to $0.15 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -40.2%
- 5-Year CAGR
- -38.8%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 192This company $0.15 Sector average $3.54
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 37.3% year-over-year.
- Ranks #48 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | +37.3% |
| FY2024 | $0.11 | -74.1% |
| FY2023 | $0.41 | -39.8% |
| FY2022 | $0.69 | +0.3% |
| FY2021 | $0.68 | -59.9% |
| FY2020 | $1.71 | -11.6% |
| FY2019 | $1.93 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026